Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Diabetic Foot | Research

Nasal MRSA carriage is a risk factor for development of antibiotic resistance in diabetic foot ulcers and is significantly higher than diabetic and non-diabetic individuals without foot ulcer

Authors: Poulami Mukherjee, Shouvik Paul, Tanmoy Dutta, Shankha Nath, Bikramaditya Ghosh, Debika Chatterjee, Satinath Mukhopadhyay, Souvik Mukherjee

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Diabetic foot ulcer (DFU) is a major complication of diabetes often impacted by polymicrobial infection in the wound site. Diabetic patients are immunocompromised in nature and hence vulnerable to infection once the skin barrier is breached. Microbiological culture-based methods show that Staphylococcus aureus (SA) is the most frequently isolated bacteria from the DFU wounds. SA and its most clinically important antibiotic resistant variant methicillin-resistant S. aureus (MRSA) are commonly found in the nasal vestibule and colonization of SA as well as MRSA in any wound site can aggravate the condition. We hypothesize that the presence of nasal MRSA carriage can serve as a potential risk factor contributing to the emergence of antibiotic resistance in diabetic foot ulcer wounds.

Methods

In the present study, we have compared the carriage of SA and MRSA in nasal cavity and foot skin among DFU patients (D+F+, n = 50), diabetic patients without any ulcer (D+F-, n = 50), and healthy controls (D-F-, n = 40) by using bacterial culture and PCR based methods. The D+F+, D+F- and D-F-individuals were further categorized based on the presence or absence of MRSA and clinical parameters were compared between MRSA+ ve and MRSA-ve individuals in each of the three groups mentioned above.

Results

Our results show that, (a) nasal MRSA carriage is significantly higher (p < 0.05) in D+F+ group than the D+F- and D-F- and significantly associated with wound MRSA carriage in D+ F+ individuals (O.R. = 4.09; 95% C.I. = 1.12–15.05) and (b) the HbA1C level is significantly higher (p < 0.02) in wound MRSA positive, compared to MRSA negative D+F+ patients. Interestingly more than half of the MRSA (64%) isolated from DFU wound were identified to be multidrug resistant.

Conclusion

These findings strongly suggest that nasal MRSA carriage can act as a risk factor for development of antibiotic resistance in diabetic foot ulcers and it is therefore important to screen nasal and wound sites of these patients regularly. We have also developed a rapid multiplex PCR assay to detect MRSA from clinical isolates or microbial DNA isolated from clinical samples in the hospital settings.
Literature
2.
go back to reference Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (ADFC Study)—Two-Year Follow-Up Study. Int J Endocrinol. 2018;2018:7631659.CrossRefPubMedPubMedCentral Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (ADFC Study)—Two-Year Follow-Up Study. Int J Endocrinol. 2018;2018:7631659.CrossRefPubMedPubMedCentral
3.
go back to reference Hobizal KB, Wukich DK. Diabetic foot infections: current concept review. Diabet Foot Ankle. 2012;3:1–8.CrossRef Hobizal KB, Wukich DK. Diabetic foot infections: current concept review. Diabet Foot Ankle. 2012;3:1–8.CrossRef
4.
go back to reference Suryaletha K, John J, Radhakrishnan MP, George S, Thomas S. Metataxonomic approach to decipher the polymicrobial burden in diabetic foot ulcer and its biofilm mode of infection. Int Wound J. 2018;15:473–81.CrossRefPubMedPubMedCentral Suryaletha K, John J, Radhakrishnan MP, George S, Thomas S. Metataxonomic approach to decipher the polymicrobial burden in diabetic foot ulcer and its biofilm mode of infection. Int Wound J. 2018;15:473–81.CrossRefPubMedPubMedCentral
5.
go back to reference Kalan LR, Meisel JS, Loesche MA, Horwinski J, Soaita I, Chen X, et al. Strain- and Species-Level Variation in the Microbiome of Diabetic Wounds Is Associated with Clinical Outcomes and Therapeutic Efficacy. Cell Host Microbe. 2019;25:641-655.e5.CrossRefPubMedPubMedCentral Kalan LR, Meisel JS, Loesche MA, Horwinski J, Soaita I, Chen X, et al. Strain- and Species-Level Variation in the Microbiome of Diabetic Wounds Is Associated with Clinical Outcomes and Therapeutic Efficacy. Cell Host Microbe. 2019;25:641-655.e5.CrossRefPubMedPubMedCentral
6.
go back to reference Malone M, Johani K, Jensen SO, Gosbell IB, Dickson HG, Hu H, et al. Next Generation DNA Sequencing of Tissues from Infected Diabetic Foot Ulcers. EBioMedicine. 2017;21:142–9.CrossRefPubMedPubMedCentral Malone M, Johani K, Jensen SO, Gosbell IB, Dickson HG, Hu H, et al. Next Generation DNA Sequencing of Tissues from Infected Diabetic Foot Ulcers. EBioMedicine. 2017;21:142–9.CrossRefPubMedPubMedCentral
7.
go back to reference Heravi FS, Zakrzewski M, Vickery K, Armstrong DG, Hu H. Bacterial Diversity of Diabetic Foot Ulcers: Current Status and Future Prospectives. J Clin Med. 2019;8. Heravi FS, Zakrzewski M, Vickery K, Armstrong DG, Hu H. Bacterial Diversity of Diabetic Foot Ulcers: Current Status and Future Prospectives. J Clin Med. 2019;8.
8.
go back to reference McCallum N, Berger-Bächi B, Senn MM. Regulation of antibiotic resistance in Staphylococcus aureus. Int J Med Microbiol. 2010;300:118–29.CrossRefPubMed McCallum N, Berger-Bächi B, Senn MM. Regulation of antibiotic resistance in Staphylococcus aureus. Int J Med Microbiol. 2010;300:118–29.CrossRefPubMed
9.
go back to reference Dunyach-Remy C, Courtais-Coulon C, DeMattei C, Jourdan N, Schuldiner S, Sultan A, et al. Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers. Diabetes Metab. 2017;43:167–71.CrossRefPubMed Dunyach-Remy C, Courtais-Coulon C, DeMattei C, Jourdan N, Schuldiner S, Sultan A, et al. Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers. Diabetes Metab. 2017;43:167–71.CrossRefPubMed
10.
go back to reference Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006;12:186–9.CrossRefPubMed Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006;12:186–9.CrossRefPubMed
11.
go back to reference Shettigar K, Jain S, Bhat DV, Acharya R, Ramachandra L, Satyamoorthy K, et al. Virulence determinants in clinical Staphylococcus aureus from monomicrobial and polymicrobial infections of diabetic foot ulcers. J Med Microbiol. 2016;65:1392–404.CrossRefPubMed Shettigar K, Jain S, Bhat DV, Acharya R, Ramachandra L, Satyamoorthy K, et al. Virulence determinants in clinical Staphylococcus aureus from monomicrobial and polymicrobial infections of diabetic foot ulcers. J Med Microbiol. 2016;65:1392–404.CrossRefPubMed
12.
go back to reference Dang CN, Prasad YDM, Boulton AJM, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2003;20:159–61.CrossRefPubMed Dang CN, Prasad YDM, Boulton AJM, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2003;20:159–61.CrossRefPubMed
13.
go back to reference Ramsey MM, Freire MO, Gabrilska RA, Rumbaugh KP, Lemon KP. Staphylococcus aureus Shifts toward Commensalism in Response to Corynebacterium Species. Front Microbiol. 2016;7 AUG. Ramsey MM, Freire MO, Gabrilska RA, Rumbaugh KP, Lemon KP. Staphylococcus aureus Shifts toward Commensalism in Response to Corynebacterium Species. Front Microbiol. 2016;7 AUG.
14.
go back to reference Allende JMB, Sánchez MG, Caso AA. Osteomyelitis. Med. 2022;13:3041–9. Allende JMB, Sánchez MG, Caso AA. Osteomyelitis. Med. 2022;13:3041–9.
15.
go back to reference Stańkowska M, Garbacz K, Korzon-Burakowska A, Bronk M, Skotarczak M, Szymańska-Dubowik A. Microbiological, Clinical and Radiological Aspects of Diabetic Foot Ulcers Infected with Methicillin-Resistant and -Sensitive Staphylococcus aureus. Pathogens. 2022;11. Stańkowska M, Garbacz K, Korzon-Burakowska A, Bronk M, Skotarczak M, Szymańska-Dubowik A. Microbiological, Clinical and Radiological Aspects of Diabetic Foot Ulcers Infected with Methicillin-Resistant and -Sensitive Staphylococcus aureus. Pathogens. 2022;11.
17.
go back to reference Anafo RB, Atiase Y, Kotey FCN, Dayie NTKD, Tetteh-Quarcoo PB, Duodu S, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital. PLoS ONE. 2021;16:e0257004.CrossRefPubMedPubMedCentral Anafo RB, Atiase Y, Kotey FCN, Dayie NTKD, Tetteh-Quarcoo PB, Duodu S, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital. PLoS ONE. 2021;16:e0257004.CrossRefPubMedPubMedCentral
18.
go back to reference Vn U, No N, Cn O-N, Nf O-N. Diabetes & Obesity International Journal Committed to Create Value for Researchers Risk Factors for Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetes Patients with Foot Ulcers (DFU) in a Tertiary Hospital Diabetes Obes Int J Risk Factors for Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetes Patients with Foot Ulcers (DFU) in a Tertiary Hospital. 2022. https://doi.org/10.23880/doij-16000254. Vn U, No N, Cn O-N, Nf O-N. Diabetes & Obesity International Journal Committed to Create Value for Researchers Risk Factors for Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetes Patients with Foot Ulcers (DFU) in a Tertiary Hospital Diabetes Obes Int J Risk Factors for Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetes Patients with Foot Ulcers (DFU) in a Tertiary Hospital. 2022. https://​doi.​org/​10.​23880/​doij-16000254.
19.
go back to reference Haleem A, Schultz JS, Heilmann KP, Dohrn CL, Diekema DJ, Gardner SE. Concordance of nasal and diabetic foot ulcer staphylococcal colonization. Diagn Microbiol Infect Dis. 2014;79:85.CrossRefPubMedPubMedCentral Haleem A, Schultz JS, Heilmann KP, Dohrn CL, Diekema DJ, Gardner SE. Concordance of nasal and diabetic foot ulcer staphylococcal colonization. Diagn Microbiol Infect Dis. 2014;79:85.CrossRefPubMedPubMedCentral
20.
go back to reference Lavery LA, La Fontaine J, Bhavan K, Kim PJ, Williams JR, Hunt NA. Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections. Diabet Foot Ankle. 2014;5. Lavery LA, La Fontaine J, Bhavan K, Kim PJ, Williams JR, Hunt NA. Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections. Diabet Foot Ankle. 2014;5.
21.
go back to reference Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg. 1996;35:528–31.CrossRefPubMed Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg. 1996;35:528–31.CrossRefPubMed
22.
go back to reference Monteiro-Soares M, Hamilton EJ, Russell DA, Srisawasdi G, Boyko EJ, Mills JL, et al. Guidelines on the classification of foot ulcers in people with diabetes (IWGDF update). Diabetes Metab Res Rev. 2023;2023:e3648.CrossRef Monteiro-Soares M, Hamilton EJ, Russell DA, Srisawasdi G, Boyko EJ, Mills JL, et al. Guidelines on the classification of foot ulcers in people with diabetes (IWGDF update). Diabetes Metab Res Rev. 2023;2023:e3648.CrossRef
23.
go back to reference Rastogi A, Bhansali A. Diabetic Foot Infection: An Indian Scenario The Journal of Foot and Ankle Surgery. 3:71–9. Rastogi A, Bhansali A. Diabetic Foot Infection: An Indian Scenario The Journal of Foot and Ankle Surgery. 3:71–9.
25.
go back to reference Cheng HR, Jiang N. Extremely rapid extraction of DNA from bacteria and yeasts. Biotechnol Lett. 2006;28:55–9.CrossRefPubMed Cheng HR, Jiang N. Extremely rapid extraction of DNA from bacteria and yeasts. Biotechnol Lett. 2006;28:55–9.CrossRefPubMed
26.
go back to reference Jaffe RI, Lane JD, Albury SV, Niemeyer DM. Rapid extraction from and direct identification in clinical samples of methicillin-resistant staphylococci using the PCR. J Clin Microbiol. 2000;38:3407–12.CrossRefPubMedPubMedCentral Jaffe RI, Lane JD, Albury SV, Niemeyer DM. Rapid extraction from and direct identification in clinical samples of methicillin-resistant staphylococci using the PCR. J Clin Microbiol. 2000;38:3407–12.CrossRefPubMedPubMedCentral
27.
go back to reference Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol. 1992;30:1654.CrossRefPubMedPubMedCentral Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol. 1992;30:1654.CrossRefPubMedPubMedCentral
28.
go back to reference Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol. 1991;29:2240.CrossRefPubMedPubMedCentral Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol. 1991;29:2240.CrossRefPubMedPubMedCentral
29.
go back to reference Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens MJ. Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol. 2002;40:1514–7.CrossRefPubMedPubMedCentral Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens MJ. Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol. 2002;40:1514–7.CrossRefPubMedPubMedCentral
30.
go back to reference Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–32.CrossRefPubMed Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128–32.CrossRefPubMed
33.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed
34.
go back to reference Lin SY, Lin NY, Huang YY, Hsieh CC, Huang YC. Methicillin-resistant Staphylococcus aureus nasal carriage and infection among patients with diabetic foot ulcer. J Microbiol Immunol Infect. 2020;53:292–9.CrossRefPubMed Lin SY, Lin NY, Huang YY, Hsieh CC, Huang YC. Methicillin-resistant Staphylococcus aureus nasal carriage and infection among patients with diabetic foot ulcer. J Microbiol Immunol Infect. 2020;53:292–9.CrossRefPubMed
35.
go back to reference Tascini C. Resistant Infections in the Diabetic Foot: A Frightening Scenario. Front Diabetes. 2018;26:161–6.CrossRef Tascini C. Resistant Infections in the Diabetic Foot: A Frightening Scenario. Front Diabetes. 2018;26:161–6.CrossRef
36.
go back to reference Wertheim HFL, Melles DC, Vos MC, Van Leeuwen W, Van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–62.CrossRefPubMed Wertheim HFL, Melles DC, Vos MC, Van Leeuwen W, Van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–62.CrossRefPubMed
37.
go back to reference Lecube A, Pachón G, Petriz J, Hernández C, Simó R. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One. 2011;6. Lecube A, Pachón G, Petriz J, Hernández C, Simó R. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One. 2011;6.
38.
go back to reference Viswanathan V, Pendsey S, Radhakrishnan C, Rege TD, Ahdal J, Jain R. Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infection in India: A Growing Menace. Int J Low Extrem Wounds. 2019;18:236–46.CrossRefPubMed Viswanathan V, Pendsey S, Radhakrishnan C, Rege TD, Ahdal J, Jain R. Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infection in India: A Growing Menace. Int J Low Extrem Wounds. 2019;18:236–46.CrossRefPubMed
Metadata
Title
Nasal MRSA carriage is a risk factor for development of antibiotic resistance in diabetic foot ulcers and is significantly higher than diabetic and non-diabetic individuals without foot ulcer
Authors
Poulami Mukherjee
Shouvik Paul
Tanmoy Dutta
Shankha Nath
Bikramaditya Ghosh
Debika Chatterjee
Satinath Mukhopadhyay
Souvik Mukherjee
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08673-3

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine